About this trial
This study focuses on swallowing dysfunction, a common issue affecting 60-75% of head and neck cancer patients due to tumor damage, treatment complications, and chemoradiotherapy side effects, which can lead to malnutrition and reduced quality of life. With limited research on the effects of radiation doses on swallowing muscles and nutrition, this study aims to evaluate these impacts in non-surgical patients undergoing radiotherapy, conducting assessments before treatment, three months after, and within one year post-treatment.
Eligibility criteria
Qualifiers
Patients scheduled to undergo radiotherapy or concurrent chemoradiotherapy ;
Aged between 18 and 80 years;
Able to perform self-care independently (ECOG ≤ 2);
All patients provide written informed consent.
Disqualifiers
Patients scheduled to undergo surgical treatment;
Patients with neuromuscular diseases, such as stroke or Parkinson's disease;
Patients with other diseases or complications, including heart disease classified as NYHA functional class ≥ 2 with thrombotic conditions, or lung disease classified as Hugh-Jones grade ≥ 4;
Patients with psychological disorders that may affect their ability to provide informed consent or comply with the study protocol;
Trial design
Treatments tested in this trial
- Not listed